Bulut Gökten D, Mercan R. Clinical Outcomes after Switching from Originator Infliximab to the Biosimilar Ixifi in Patients with Axial Spondyloarthritis: A Single-Center Study from Türkiye. Rheumatol Bul. 2026;34(1):4-20. doi:10.35465/wx09tq86